Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The potential of genetic testing for chronic disease is substantial—and these possible positives are understood by many primary care providers (PCPs). Still, many feel unprepared to deal with patients at high risk for such conditions, while others questioned their ability to interpret genetic testing results.
The potential of genetic testing for chronic disease is substantial—and these possible positives are understood by many primary care providers (PCPs). Still, many feel unprepared to deal with patients at high risk for such conditions, while others questioned their ability to interpret genetic testing results.
Fitbit has announced, in addition to its app tracking steps and sleep patterns, the integration of menstrual cycle tracking into their smartwatch technology.
Researchers at the University of Texas at Arlington have developed a flexible biodegradable hydrogel capable of printing human tissues. The team published its findings March 18 in ACS Applied Materials and Interfaces.
Clinical decision support systems (CDSSs) have shown potential in reducing medical errors and improving patient outcomes, but utilization remains low due to a lack of user acceptance, according to a study published April 18 in JMIR Medical Informatics.
Researchers at the University of Washington in Seattle have created an exercise platform that uses crowdsourcing data to create personalized workout plans that adhere to national exercise recommendations.
Researchers from Tel Aviv University in Israel and Linköping University in Sweden have developed a retinal prosthesis that could restore vision in blind patients, according to research published May 2 in Advanced Materials.
A report commissioned by the Massachusetts Health & Hospital Association found it would cost the state’s hospitals nearly $1 billion a year to comply with a proposed ballot initiative to set limits on the number of patients a hospital can assign to a nurse per shift.
